BKD Quote, Financials, Valuation and Earnings

Guardian Pharmacy Services has a net margin of -7.98% compared to Brookdale Senior Living's net margin of 2.87%. Brookdale Senior Living's return on equity of -86.4% beat Guardian Pharmacy Services's return on equity of -71.46%.

Brookdale Senior Living has a consensus price target of $7.70, signalling downside risk potential of -0.9%. On the other hand Guardian Pharmacy Services has an analysts' consensus of $27.33 which suggests that it could grow by 31.54%. Given that Guardian Pharmacy Services has higher upside potential than Brookdale Senior Living, analysts believe Guardian Pharmacy Services is more attractive than Brookdale Senior Living.

Brookdale Senior Living has a beta of 0.828, which suggesting that the stock is 17.157% less volatile than S&P 500. In comparison Guardian Pharmacy Services has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Brookdale Senior Living has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardian Pharmacy Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookdale Senior Living pays -- of its earnings as a dividend. Guardian Pharmacy Services pays out -40.96% of its earnings as a dividend.

Brookdale Senior Living quarterly revenues are $813.9M, which are larger than Guardian Pharmacy Services quarterly revenues of $329.3M. Brookdale Senior Living's net income of -$65M is lower than Guardian Pharmacy Services's net income of $9.4M. Notably, Brookdale Senior Living's price-to-earnings ratio is -- while Guardian Pharmacy Services's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookdale Senior Living is 0.56x versus 1.01x for Guardian Pharmacy Services. Usually stocks with elevated PS ratios are considered overvalued.

LifeStance Health Group has a net margin of -7.98% compared to Brookdale Senior Living's net margin of 0.21%. Brookdale Senior Living's return on equity of -86.4% beat LifeStance Health Group's return on equity of -2.48%.

Brookdale Senior Living has a consensus price target of $7.70, signalling downside risk potential of -0.9%. On the other hand LifeStance Health Group has an analysts' consensus of $8.50 which suggests that it could grow by 93.18%. Given that LifeStance Health Group has higher upside potential than Brookdale Senior Living, analysts believe LifeStance Health Group is more attractive than Brookdale Senior Living.

Brookdale Senior Living has a beta of 0.828, which suggesting that the stock is 17.157% less volatile than S&P 500. In comparison LifeStance Health Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Brookdale Senior Living has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeStance Health Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookdale Senior Living pays -- of its earnings as a dividend. LifeStance Health Group pays out -- of its earnings as a dividend.

Brookdale Senior Living quarterly revenues are $813.9M, which are larger than LifeStance Health Group quarterly revenues of $333M. Brookdale Senior Living's net income of -$65M is lower than LifeStance Health Group's net income of $709K. Notably, Brookdale Senior Living's price-to-earnings ratio is -- while LifeStance Health Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookdale Senior Living is 0.56x versus 1.31x for LifeStance Health Group. Usually stocks with elevated PS ratios are considered overvalued.

PACS Group has a net margin of -7.98% compared to Brookdale Senior Living's net margin of -1.11%. Brookdale Senior Living's return on equity of -86.4% beat PACS Group's return on equity of --.

Brookdale Senior Living has a consensus price target of $7.70, signalling downside risk potential of -0.9%. On the other hand PACS Group has an analysts' consensus of $30.50 which suggests that it could grow by 146.96%. Given that PACS Group has higher upside potential than Brookdale Senior Living, analysts believe PACS Group is more attractive than Brookdale Senior Living.

Brookdale Senior Living has a beta of 0.828, which suggesting that the stock is 17.157% less volatile than S&P 500. In comparison PACS Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Brookdale Senior Living has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookdale Senior Living pays -- of its earnings as a dividend. PACS Group pays out 71.23% of its earnings as a dividend. PACS Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Brookdale Senior Living quarterly revenues are $813.9M, which are smaller than PACS Group quarterly revenues of $981.8M. Brookdale Senior Living's net income of -$65M is lower than PACS Group's net income of -$10.9M. Notably, Brookdale Senior Living's price-to-earnings ratio is -- while PACS Group's PE ratio is 20.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookdale Senior Living is 0.56x versus 0.54x for PACS Group. Usually stocks with elevated PS ratios are considered overvalued.

Pennant Group has a net margin of -7.98% compared to Brookdale Senior Living's net margin of 3.71%. Brookdale Senior Living's return on equity of -86.4% beat Pennant Group's return on equity of 10.97%.

Brookdale Senior Living has a consensus price target of $7.70, signalling downside risk potential of -0.9%. On the other hand Pennant Group has an analysts' consensus of $32.80 which suggests that it could grow by 38.05%. Given that Pennant Group has higher upside potential than Brookdale Senior Living, analysts believe Pennant Group is more attractive than Brookdale Senior Living.

Brookdale Senior Living has a beta of 0.828, which suggesting that the stock is 17.157% less volatile than S&P 500. In comparison Pennant Group has a beta of 1.512, suggesting its more volatile than the S&P 500 by 51.208%.

Brookdale Senior Living has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brookdale Senior Living pays -- of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend.

Brookdale Senior Living quarterly revenues are $813.9M, which are larger than Pennant Group quarterly revenues of $209.8M. Brookdale Senior Living's net income of -$65M is lower than Pennant Group's net income of $7.8M. Notably, Brookdale Senior Living's price-to-earnings ratio is -- while Pennant Group's PE ratio is 31.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brookdale Senior Living is 0.56x versus 1.05x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.